Life Science Compliance Update



Pricing Bills Are Popping Up Everywhere

Written by , Posted in Pricing

Nicodemo (Nico) Fiorentino, Esq., Senior Advisor, Research & Compliance, for G&M Health LLC, and Editorial Board Member, Life Science Compliance Update and Christina Bello, Esq., Regulatory Compliance Advisor, for G&M Health LLC

The price of prescription drugs has created much controversy in recent years. This article examines why the pharmaceutical industry is under such scrutiny despite the fact that expenditures for drug costs have remained steady, explores State and federal legislative response to this perceived problem, and posits the future regulatory landscape regarding prescription drug pricing.


Topic tags:

Menu Title